FDA, NSF, NHLBI, NINDS | GenomeWeb

FDA Releases Pharmacogenomics Data Submission Guidance

The US Food and Drug Administration this week released its Pharmacogenomics Data Submissions guidance.

Released in draft form in November 2003, and then delayed numerous times before being released in its final form, the guidance may encourage drug makers to use pharmacogenomics technologies in their drug-discovery efforts. This in turn may spur greater investment in SNP-genotyping, gene expression, RNAi, and gene sequencing technologies and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.